Reversible sensorineural hearing loss following administration of muromonab-CD3 (OKT3) for cadaveric renal transplant immunosuppression.

Source:http://linkedlifedata.com/resource/pubmed/id/10651411

Download in:

View as

General Info

PMID
10651411